BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29
• 30

• Press Releases

  PumasAI Brings AI, Scientific Machine Learning and Advanced Pharmacometric Research to ACoP 2026

  Pre-conference workshop on the future of AI in pharmacometrics and four scientific poster presentations highlight PumasAI’s presence at the American Conference on Pharmacometrics

  October 1, 2026

   · 

  1 min read
• Press Releases

  Orimed Pharma launches PrBALANSYA®, Canada’s only escitalopram oral solution

  October 1, 2026

   · 

  3 min read
• Press Releases

  PearlMatrix® P-15 Peptide Enhanced Bone Graft Receives Medicare New Technology Add-on Payment (NTAP), Helping Hospitals Accelerate Lumbar Fusion

  October 1, 2026

   · 

  6 min read
• Press Releases

  NORD Awards Seed Grants to Advance Breakthroughs in Rare Disease Research

  October 1, 2026

   · 

  7 min read
• Press Releases

  ADARx Pharmaceuticals Announces the Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares Granted in Its Initial Public Offering

  October 1, 2026

   · 

  3 min read
• Press Releases

  NANOBIOTIX Announces the Appointment of Arnd Christ as Chief Financial Officer

  October 1, 2026

   · 

  5 min read
• Press Releases

  Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - October 1, 2026

  October 1, 2026

   · 

  2 min read
• Press Releases

  Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - October 1, 2026

  October 1, 2026

   · 

  1 min read
• Press Releases

  Resmed to Report First Quarter Fiscal 2027 Earnings on October 29, 2026

  October 1, 2026

   · 

  1 min read
• Press Releases

  Mineralys Therapeutics Announces Presentation of Lorundrostat Data at American Heart Association Hypertension Scientific Sessions 2026

  October 1, 2026

   · 

  8 min read